These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 822988)

  • 1. Mesoridazine in Huntington's disease (chorea): effect on weight, dyskinesia, and mental function.
    Drymiotis A; Korenyi C; Whittier JR
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):300-7. PubMed ID: 822988
    [No Abstract]   [Full Text] [Related]  

  • 2. Dyskinesia analysis. Histogram analysis of cineseismograms of human dyskinesia.
    Korenyi C; Whittier JR
    Dis Nerv Syst; 1974 Apr; 35(4):169-71. PubMed ID: 17894112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of chorea in Huntington's disease by power spectral analysis.
    Weitzman DO; Rosfnfeld C; Korenyl C; Whittier JR
    Dis Nerv Syst; 1976 May; 37(5):264-8. PubMed ID: 131027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of mesoridazine in geriatrics.
    Goldstein SE
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):316-23. PubMed ID: 4208348
    [No Abstract]   [Full Text] [Related]  

  • 5. Chlordiazepoxide in the treatment of patients with "activated EEG's".
    Monroe RR; Dale R
    Dis Nerv Syst; 1967 Jun; 28(6):390-6. PubMed ID: 5340423
    [No Abstract]   [Full Text] [Related]  

  • 6. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Jankovic J
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral fluphenazine on Huntington's chorea.
    Whittier JR; Korenyi C
    Int J Neuropsychiatry; 1968 Feb; 4(1):1-3. PubMed ID: 4230793
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug treatment of the alcohol withdrawal syndrome and delirium tremens. A comparison of haloperidol with mesoridazine and hydroxyzine.
    Palestine ML
    Q J Stud Alcohol; 1973 Mar; 34(1):185-93. PubMed ID: 4572441
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mesoridazine (TPS 23 Sandoz) in acute psychotic states].
    Jost F; Zmorski T
    Schweiz Arch Neurol Neurochir Psychiatr; 1973; 112(1):131-42. PubMed ID: 4570413
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD
    Neurology; 1970 Dec; 20(12):Suppl:6-13. PubMed ID: 4921587
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical trial with mesoridazine (another phenodiazine derivative).
    Rudy L; Marozas RJ; Sykes D; Smith JA
    Dis Nerv Syst; 1968 Jun; 29(6):412-3. PubMed ID: 4877749
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic experience with transdihydrolisuride in Huntington's disease.
    Bassi S; Albizzati MG; Corsini GU; Frattola L; Piolti R; Suchy I; Trabucchi M
    Neurology; 1986 Jul; 36(7):984-6. PubMed ID: 2940475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flupentixol and flupentixol decanoate, with special reference to their antipsychotic effect.
    Gottfries CG
    Acta Psychiatr Belg; 1974 Sep; 74(5):507-16. PubMed ID: 4620362
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trial of tiapride in patients with dyskinesia (author's transl)].
    Chouza C; Romero S; Lorenzo J; Camano JL; Fontana AP; Alterwain P; Cibils D; Gaudiano J; Feres S; Solana J
    Sem Hop; 1982 Mar; 58(12):725-33. PubMed ID: 6283645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
    Kenney C; Hunter C; Davidson A; Jankovic J
    Mov Disord; 2007 Jan; 22(1):10-3. PubMed ID: 17078062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic evaluation of mesoridazine (Serentil).
    Dillenkoffer RL; Gallant DM; Phillips JH
    Curr Ther Res Clin Exp; 1972 Feb; 14(2):71-2. PubMed ID: 4622440
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous mesoridazine and psychodrama in neurotics.
    Lapierre YD; Lavallée J; Tétreault L
    Int J Clin Pharmacol; 1973 Feb; 7(1):62-6. PubMed ID: 4699386
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of handwriting of patients with Huntington's disease.
    Phillips JG; Bradshaw JL; Chiu E; Bradshaw JA
    Mov Disord; 1994 Sep; 9(5):521-30. PubMed ID: 7990847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoridazine in neuroleptic-resistant psychoses.
    Osser DN; Albert LG; Figueiredo S; O'Connor H; Barden Y; Carmichael WG
    J Clin Psychopharmacol; 1991 Oct; 11(5):328-30. PubMed ID: 1684976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.